Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
- Conditions
- Epilepsy; Seizure
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Empatica, Inc.
- Target Recruit Count
- 3000
- Registration Number
- NCT06275685
- Locations
- 🇺🇸
Empatica, Boston, Massachusetts, United States
EmbracePlus SpO2 Accuracy Validation
- Conditions
- Oximetry
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2022-11-25
- Lead Sponsor
- Empatica, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT04964609
- Locations
- 🇺🇸
Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California, San Francisco, California, United States
EmbracePlus, Care App and Aura Usability Study
- Conditions
- Usability
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Empatica, Inc.
- Target Recruit Count
- 335
- Registration Number
- NCT04807608
- Locations
- 🇺🇸
Empatica Inc, Boston, Massachusetts, United States
Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System
- Conditions
- Epilepsy
- First Posted Date
- 2017-07-05
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- Empatica, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03207685
- Locations
- 🇺🇸
NYU Langone Medical Center, New York, New York, United States
🇮🇹Ospedale Pediatrico Bambino Gesù - Department of Neuroscience, Neurology Unit, Roma, Italy
Embrace: Seizure Characterization
- Conditions
- Epilepsy
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- Empatica, Inc.
- Target Recruit Count
- 100000
- Registration Number
- NCT03206502